NYSE · Biotechnology

Ginkgo Bioworks Holdings (DNA)

$7.40 +6.32%
46 In band Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$8.68-14.75%

Company profile

Ginkgo Bioworks Holdings (DNA) is a pioneering force in synthetic biology, leveraging advanced genetic engineering to create customized bioengineered organisms suitable for a wide range of sectors, including pharmaceuticals, agriculture, and industrial biotechnology. The company's innovative platform streamlines cellular design and manufacturing, positioning Ginkgo as a key player in addressing critical global challenges such as climate change and food security. With a strong focus on sustainable biotechnology solutions, Ginkgo is well-equipped to tap into the increasing market demand for bio-based alternatives, highlighting its potential for significant growth and transformative impact across various industries.

SectorHealthcare
IndustryBiotechnology
Market cap$515.15M
P/E ratioNone
EPS$-5.12
Beta1.789
Dividend yield0.00%
52-week high$17.58
52-week low$5.37

Similar stocks in Biotechnology

Free forever

RSI alerts for DNA

Get an email the moment Ginkgo Bioworks Holdings crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 7:15 AM EDT